The Oncomine database also showed that AXL expression was positively correlated with advanced tumor stages (Figure 1B) and lymph node status (Figure 1C) of breast cancer patients, suggesting that AXL is crucial for tumor progression and survival outcomes in breast cancer patients. Here, AXL is linked to breast carcinoma.